Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Total Parent Equity	Total Parent Equity Cumulative Effect, Period of Adoption, Adjustment	Non- controlling Interests in Subsidiaries
Beginning balance at Dec. 31, 2019							$ 6,000
Ending balance (in shares) at Dec. 31, 2020			144,354,335
Ending balance at Dec. 31, 2020	$ 3,218,003	$ 6,223	$ 144,354	$ 117,165	$ (1,036,502)	$ 3,979,779	$ 6,223	$ 3,204,796	$ 6,223	$ 13,207
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2019-12 [Member]
Net income	$ 898,790					898,790		898,790
Other comprehensive (loss) income, net of tax	178,763				178,763			178,763
Cash dividends declared	(467,482)					(467,482)		(467,482)
Share-based awards exercised, including tax benefit (in shares)			440,667
Share-based awards exercised, including tax benefit	(22,346)		$ 441	(22,787)				(22,346)
Share-based compensation	25,597			25,597				25,597
Purchase of stock (in shares)			(2,614,319)
Purchase of stock	(333,599)		$ (2,614)			(330,985)		(333,599)
Noncontrolling interest activities	(659)									(659)
Ending balance (in shares) at Dec. 31, 2021			142,180,683
Ending balance at Dec. 31, 2021	3,503,290		$ 142,181	119,975	(857,739)	4,086,325		3,490,742		12,548
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,182,701					1,182,701		1,182,701
Other comprehensive (loss) income, net of tax	(174,803)				(174,803)			(174,803)
Cash dividends declared	(506,232)					(506,232)		(506,232)
Share-based awards exercised, including tax benefit (in shares)			333,185
Share-based awards exercised, including tax benefit	(17,377)		$ 332	(17,709)				(17,377)
Share-based compensation	38,058			38,058				38,058
Purchase of stock (in shares)			(1,572,219)
Purchase of stock	(222,726)		$ (1,572)			(221,154)		(222,726)
Noncontrolling interest activities	$ 1,536									1,536
Ending balance (in shares) at Dec. 31, 2022	140,941,649		140,941,649
Ending balance at Dec. 31, 2022	$ 3,804,447		$ 140,941	140,324	(1,032,542)	4,541,640		3,790,363		14,084
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,316,524					1,316,524		1,316,524
Other comprehensive (loss) income, net of tax	55,670				55,670			55,670
Cash dividends declared	(533,118)					(533,118)		(533,118)
Share-based awards exercised, including tax benefit (in shares)			380,376
Share-based awards exercised, including tax benefit	(24,145)		$ 380	(24,525)				(24,145)
Share-based compensation	57,226			57,226				57,226
Purchase of stock (in shares)			(1,754,954)
Purchase of stock	(261,473)		$ (1,754)			(259,719)		(261,473)
Noncontrolling interest activities	$ 1,854									1,854
Ending balance (in shares) at Dec. 31, 2023	139,567,071		139,567,071
Ending balance at Dec. 31, 2023	$ 4,416,985		$ 139,567	$ 173,025	$ (976,872)	$ 5,065,327		$ 4,401,047		$ 15,938